# FDA approvals of specialty drugs, 2000-2024

**Authors:** Sophie E Knox, Claire H Brennan, Daniel E Enright, Peter J Neumann, James D Chambers

PMC · DOI: 10.1093/haschl/qxag035 · Health Affairs Scholar · 2026-02-07

## Full-text entities

- **Diseases:** rare diseases (MESH:D035583), autoimmune disorders (MESH:D001327), cancer (MESH:D009369), immune-mediated, genetic, and neurologic disorders (MESH:D020274)
- **Chemicals:** PBM (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12927497/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12927497/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12927497/full.md

---
Source: https://tomesphere.com/paper/PMC12927497